These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 24964990)

  • 41. Nipah virus: epidemiology, pathology, immunobiology and advances in diagnosis, vaccine designing and control strategies - a comprehensive review.
    Singh RK; Dhama K; Chakraborty S; Tiwari R; Natesan S; Khandia R; Munjal A; Vora KS; Latheef SK; Karthik K; Singh Malik Y; Singh R; Chaicumpa W; Mourya DT
    Vet Q; 2019 Dec; 39(1):26-55. PubMed ID: 31006350
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A recombinant Hendra virus G glycoprotein subunit vaccine protects nonhuman primates against Hendra virus challenge.
    Mire CE; Geisbert JB; Agans KN; Feng YR; Fenton KA; Bossart KN; Yan L; Chan YP; Broder CC; Geisbert TW
    J Virol; 2014 May; 88(9):4624-31. PubMed ID: 24522928
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteins.
    Dang HV; Cross RW; Borisevich V; Bornholdt ZA; West BR; Chan YP; Mire CE; Da Silva SC; Dimitrov AS; Yan L; Amaya M; Navaratnarajah CK; Zeitlin L; Geisbert TW; Broder CC; Veesler D
    Nat Struct Mol Biol; 2021 May; 28(5):426-434. PubMed ID: 33927387
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatment.
    Rockx B; Bossart KN; Feldmann F; Geisbert JB; Hickey AC; Brining D; Callison J; Safronetz D; Marzi A; Kercher L; Long D; Broder CC; Feldmann H; Geisbert TW
    J Virol; 2010 Oct; 84(19):9831-9. PubMed ID: 20660198
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interactions of human complement with virus particles containing the Nipah virus glycoproteins.
    Johnson JB; Aguilar HC; Lee B; Parks GD
    J Virol; 2011 Jun; 85(12):5940-8. PubMed ID: 21450814
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Griffithsin Inhibits Nipah Virus Entry and Fusion and Can Protect Syrian Golden Hamsters From Lethal Nipah Virus Challenge.
    Lo MK; Spengler JR; Krumpe LRH; Welch SR; Chattopadhyay A; Harmon JR; Coleman-McCray JD; Scholte FEM; Hotard AL; Fuqua JL; Rose JK; Nichol ST; Palmer KE; O'Keefe BR; Spiropoulou CF
    J Infect Dis; 2020 May; 221(Supplement_4):S480-S492. PubMed ID: 32037447
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A single-dose ChAdOx1-vectored vaccine provides complete protection against Nipah Bangladesh and Malaysia in Syrian golden hamsters.
    van Doremalen N; Lambe T; Sebastian S; Bushmaker T; Fischer R; Feldmann F; Haddock E; Letko M; Avanzato VA; Rissanen I; LaCasse R; Scott D; Bowden TA; Gilbert S; Munster V
    PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007462. PubMed ID: 31170144
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Indirect ELISA based on Hendra and Nipah virus proteins for the detection of henipavirus specific antibodies in pigs.
    Fischer K; Diederich S; Smith G; Reiche S; Pinho Dos Reis V; Stroh E; Groschup MH; Weingartl HM; Balkema-Buschmann A
    PLoS One; 2018; 13(4):e0194385. PubMed ID: 29708971
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recent advances in the understanding of Nipah virus immunopathogenesis and anti-viral approaches.
    Pelissier R; Iampietro M; Horvat B
    F1000Res; 2019; 8():. PubMed ID: 31656582
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Optimization and diagnostic evaluation of monoclonal antibody-based blocking ELISA formats for detection of neutralizing antibodies to Hendra virus in mammalian sera.
    Di Rubbo A; McNabb L; Klein R; White JR; Colling A; Dimitrov DS; Broder CC; Middleton D; Lunt RA
    J Virol Methods; 2019 Dec; 274():113731. PubMed ID: 31513861
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nipah virus: vaccination and passive protection studies in a hamster model.
    Guillaume V; Contamin H; Loth P; Georges-Courbot MC; Lefeuvre A; Marianneau P; Chua KB; Lam SK; Buckland R; Deubel V; Wild TF
    J Virol; 2004 Jan; 78(2):834-40. PubMed ID: 14694115
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge.
    Lo MK; Feldmann F; Gary JM; Jordan R; Bannister R; Cronin J; Patel NR; Klena JD; Nichol ST; Cihlar T; Zaki SR; Feldmann H; Spiropoulou CF; de Wit E
    Sci Transl Med; 2019 May; 11(494):. PubMed ID: 31142680
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neutralization assays for differential henipavirus serology using Bio-Plex protein array systems.
    Bossart KN; McEachern JA; Hickey AC; Choudhry V; Dimitrov DS; Eaton BT; Wang LF
    J Virol Methods; 2007 Jun; 142(1-2):29-40. PubMed ID: 17292974
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ubiquitin-regulated nuclear-cytoplasmic trafficking of the Nipah virus matrix protein is important for viral budding.
    Wang YE; Park A; Lake M; Pentecost M; Torres B; Yun TE; Wolf MC; Holbrook MR; Freiberg AN; Lee B
    PLoS Pathog; 2010 Nov; 6(11):e1001186. PubMed ID: 21085610
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Lethal Aerosol Exposure Model of Nipah Virus Strain Bangladesh in African Green Monkeys.
    Prasad AN; Agans KN; Sivasubramani SK; Geisbert JB; Borisevich V; Mire CE; Lawrence WS; Fenton KA; Geisbert TW
    J Infect Dis; 2020 May; 221(Suppl 4):S431-S435. PubMed ID: 31665351
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nipah pseudovirus system enables evaluation of vaccines in vitro and in vivo using non-BSL-4 facilities.
    Nie J; Liu L; Wang Q; Chen R; Ning T; Liu Q; Huang W; Wang Y
    Emerg Microbes Infect; 2019; 8(1):272-281. PubMed ID: 30866781
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of Henipavirus infection by RNA interference.
    Mungall BA; Schopman NC; Lambeth LS; Doran TJ
    Antiviral Res; 2008 Dec; 80(3):324-31. PubMed ID: 18687361
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hendra virus and Nipah virus animal vaccines.
    Broder CC; Weir DL; Reid PA
    Vaccine; 2016 Jun; 34(30):3525-34. PubMed ID: 27154393
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Use of Large-Particle Aerosol Exposure to Nipah Virus to Mimic Human Neurological Disease Manifestations in the African Green Monkey.
    Lee JH; Hammoud DA; Cong Y; Huzella LM; Castro MA; Solomon J; Laux J; Lackemeyer M; Bohannon JK; Rojas O; Byrum R; Adams R; Ragland D; St Claire M; Munster V; Holbrook MR
    J Infect Dis; 2020 May; 221(Suppl 4):S419-S430. PubMed ID: 31687756
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of monoclonal antibodies against Hendra and Nipah viruses in an antigen capture ELISA.
    Chiang CF; Lo MK; Rota PA; Spiropoulou CF; Rollin PE
    Virol J; 2010 Jun; 7():115. PubMed ID: 20525276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.